G

Genpharmasec Ltd
BSE:531592

Watchlist Manager
Genpharmasec Ltd
BSE:531592
Watchlist
Price: 2.78 INR -3.47% Market Closed
Market Cap: 1.5B INR
Have any thoughts about
Genpharmasec Ltd?
Write Note

Genpharmasec Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Genpharmasec Ltd
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
G
Genpharmasec Ltd
BSE:531592
Interest Income Expense
-â‚ą4.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Shree Global Tradefin Ltd
BSE:512463
Interest Income Expense
-â‚ą63m
CAGR 3-Years
-543%
CAGR 5-Years
-694%
CAGR 10-Years
N/A
MSTC Ltd
NSE:MSTCLTD
Interest Income Expense
-â‚ą73.5m
CAGR 3-Years
-5%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Adani Enterprises Ltd
NSE:ADANIENT
Interest Income Expense
-â‚ą42.1B
CAGR 3-Years
-26%
CAGR 5-Years
-19%
CAGR 10-Years
3%
Refex Industries Ltd
NSE:REFEX
Interest Income Expense
-â‚ą104.9m
CAGR 3-Years
-6%
CAGR 5-Years
-111%
CAGR 10-Years
N/A
Indiamart Intermesh Ltd
NSE:INDIAMART
Interest Income Expense
â‚ą1.9B
CAGR 3-Years
50%
CAGR 5-Years
33%
CAGR 10-Years
N/A
No Stocks Found

Genpharmasec Ltd
Glance View

Market Cap
1.5B INR
Industry
Trading Companies & Distributors

Genpharmasec Ltd. engages in manufacturing and trading in Organic and Inorganic Chemicals, Dyes and Pigments Its products include potassium hydroxide and caustic soda. The company is headquartered in Mumbai, Maharashtra. The firm is engaged in the business of diagnostic equipment, pharmaceutical, medicinal, and medicated preparations, patent medicines, drugs, herbs, and in pharmaceutical, medicinal, and proprietary and industrial preparations, compounds and articles of kinds, chemists, druggists, and chemical manufacturers.

GENPHARMA Intrinsic Value
0.92 INR
Overvaluation 67%
Intrinsic Value
Price
G

See Also

What is Genpharmasec Ltd's Interest Income Expense?
Interest Income Expense
-4.5m INR

Based on the financial report for Jun 30, 2024, Genpharmasec Ltd's Interest Income Expense amounts to -4.5m INR.

What is Genpharmasec Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 1Y
-277%

Over the last year, the Interest Income Expense growth was -277%.

Back to Top